Representatives of the Centers for Disease Control and Prevention and the Food and Drug Administration spoke about their joint recommendation for a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
The event began shortly after 10 a.m.:
The state of Ohio and local health districts have followed the advice of the federal officials, pausing new administration of Johnson & Johnson doses or registration for upcoming J&J clinics.
In Other News
1
Dayton Metro Library offers help with driver’s license reinstatement...
2
NEW DETAILS: Demolition of former Fairborn school is underway
3
Greene County voters: Check what’s on your ballot in the Nov. 8...
4
Miami County voters: See what’s on your ballot in the Nov. 8 election
5
3 Springfield firefighters injured battling house fire